1
|
Zhou P, Yin JX, Tao HL, Zhang HW. Pathogenesis and management of heparin-induced thrombocytopenia and thrombosis. Clin Chim Acta 2020; 504:73-80. [DOI: 10.1016/j.cca.2020.02.002] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2019] [Revised: 01/30/2020] [Accepted: 02/03/2020] [Indexed: 01/19/2023]
|
2
|
Torshin IY, Lila AM, Gromova OA, Naumov AV, Gromov AN. On the anticoagulant and antiaggregatory properties of a glucosamine sulfate molecule. MODERN RHEUMATOLOGY JOURNAL 2019. [DOI: 10.14412/1996-7012-2019-3-135-141] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Affiliation(s)
- I. Yu. Torshin
- Institute of Pharmacoinformatics, Federal Research Center «Informatics and Management, Russian Academy of Sciences
| | - A. M. Lila
- V.A. Nasonova Research Institute of Rheumatology; Department of Rheumatology, Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia
| | - O. A. Gromova
- Institute of Pharmacoinformatics, Federal Research Center «Informatics and Management, Russian Academy of Sciences
| | - A. V. Naumov
- Russian Gerontology Research and Clinical Center, N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
| | - A. N. Gromov
- Institute of Pharmacoinformatics, Federal Research Center «Informatics and Management, Russian Academy of Sciences
| |
Collapse
|
3
|
Vaidyanathan D, Williams A, Dordick JS, Koffas MA, Linhardt RJ. Engineered heparins as new anticoagulant drugs. Bioeng Transl Med 2017; 2:17-30. [PMID: 28516163 PMCID: PMC5412866 DOI: 10.1002/btm2.10042] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2016] [Revised: 10/13/2016] [Accepted: 10/21/2016] [Indexed: 12/28/2022] Open
Abstract
Heparin is an anionic polysaccharide that is widely used as a clinical anticoagulant. This glycosaminoglycan is prepared from animal tissues in metric ton quantities. Animal-sourced heparin is also widely used in the preparation of low molecular weight heparins that are gaining in popularity as a result of their improved pharmacological properties. The recent contamination of pharmaceutical heparin together with concerns about increasing demand for this life saving drug and the fragility of the heparin supply chain has led the scientific community to consider other potential sources for heparin. This review examines progress toward the preparation of engineered heparins through chemical synthesis, chemoenzymatic synthesis, and metabolic engineering.
Collapse
Affiliation(s)
| | - Asher Williams
- Dept. of Chemical and Biological EngineeringRensselaer Polytechnic InstituteTroyNY12180
| | - Jonathan S. Dordick
- Dept. of BiologyRensselaer Polytechnic InstituteTroyNY12180
- Dept. of Chemical and Biological EngineeringRensselaer Polytechnic InstituteTroyNY12180
- Dept. of Biomedical EngineeringRensselaer Polytechnic InstituteTroyNY12180
| | - Mattheos A.G. Koffas
- Dept. of BiologyRensselaer Polytechnic InstituteTroyNY12180
- Dept. of Chemical and Biological EngineeringRensselaer Polytechnic InstituteTroyNY12180
| | - Robert J. Linhardt
- Dept. of BiologyRensselaer Polytechnic InstituteTroyNY12180
- Dept. of Chemical and Biological EngineeringRensselaer Polytechnic InstituteTroyNY12180
- Dept. of Biomedical EngineeringRensselaer Polytechnic InstituteTroyNY12180
- Dept. of Chemistry and Chemical BiologyCenter for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic InstituteTroyNY12180
| |
Collapse
|
4
|
Lima M, Nader H. Unfractionated and low molecular weight heparin. BMC Proc 2014. [PMCID: PMC4204200 DOI: 10.1186/1753-6561-8-s4-o10] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
5
|
Casu B, Naggi A, Torri G. Re-visiting the structure of heparin. Carbohydr Res 2014; 403:60-8. [PMID: 25088334 DOI: 10.1016/j.carres.2014.06.023] [Citation(s) in RCA: 88] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2014] [Accepted: 06/22/2014] [Indexed: 01/12/2023]
Abstract
The sulfated polysaccharide heparin has been used as a life-saving anticoagulant in clinics well before its detailed structure was known. This mini-review is a survey of the evolution in the discovery of the primary and secondary structure of heparin. Highlights in this history include elucidation and synthesis of the specific sequence that binds to antithrombin, the development of low-molecular-weight heparins currently used as antithrombotic drugs, and the most promising start of chemo-enzymatic synthesis. Special emphasis is given to peculiar conformational properties contributing to interaction with proteins that modulate different biological properties.
Collapse
Affiliation(s)
- Benito Casu
- G. Ronzoni Institute for Chemical and Biochemical Research, via G. Colombo, 81 20133 Milan, Italy.
| | - Annamaria Naggi
- G. Ronzoni Institute for Chemical and Biochemical Research, via G. Colombo, 81 20133 Milan, Italy
| | - Giangiacomo Torri
- G. Ronzoni Institute for Chemical and Biochemical Research, via G. Colombo, 81 20133 Milan, Italy
| |
Collapse
|
6
|
A non-hemorrhagic hybrid heparin/heparan sulfate with anticoagulant potential. Carbohydr Polym 2014; 99:372-8. [DOI: 10.1016/j.carbpol.2013.08.063] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2013] [Revised: 08/20/2013] [Accepted: 08/23/2013] [Indexed: 11/19/2022]
|
7
|
Viskov C, Elli S, Urso E, Gaudesi D, Mourier P, Herman F, Boudier C, Casu B, Torri G, Guerrini M. Heparin dodecasaccharide containing two antithrombin-binding pentasaccharides: structural features and biological properties. J Biol Chem 2013; 288:25895-25907. [PMID: 23843463 DOI: 10.1074/jbc.m113.485268] [Citation(s) in RCA: 37] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023] Open
Abstract
The antithrombin (AT) binding properties of heparin and low molecular weight heparins are strongly associated to the presence of the pentasaccharide sequence AGA*IA (A(NAc,6S)-GlcUA-A(NS,3,6S)-I(2S)-A(NS,6S)). By using the highly chemoselective depolymerization to prepare new ultra low molecular weight heparin and coupling it with the original separation techniques, it was possible to isolate a polysaccharide with a biosynthetically unexpected structure and excellent antithrombotic properties. It consisted of a dodecasaccharide containing an unsaturated uronate unit at the nonreducing end and two contiguous AT-binding sequences separated by a nonsulfated iduronate residue. This novel oligosaccharide was characterized by NMR spectroscopy, and its binding with AT was determined by fluorescence titration, NMR, and LC-MS. The dodecasaccharide displayed a significantly increased anti-FXa activity compared with those of the pentasaccharide, fondaparinux, and low molecular weight heparin enoxaparin.
Collapse
Affiliation(s)
- Christian Viskov
- Sanofi, 13 Quai Jules Guesde, 94403 Vitry sur Seine, France, and
| | - Stefano Elli
- From the Istituto di Ricerche Chimiche e Biochimiche 'G. Ronzoni', via G. Colombo 81, 20133 Milan, Italy
| | - Elena Urso
- From the Istituto di Ricerche Chimiche e Biochimiche 'G. Ronzoni', via G. Colombo 81, 20133 Milan, Italy
| | - Davide Gaudesi
- From the Istituto di Ricerche Chimiche e Biochimiche 'G. Ronzoni', via G. Colombo 81, 20133 Milan, Italy
| | - Pierre Mourier
- Sanofi, 13 Quai Jules Guesde, 94403 Vitry sur Seine, France, and
| | - Frederic Herman
- Sanofi, 13 Quai Jules Guesde, 94403 Vitry sur Seine, France, and
| | - Christian Boudier
- the Laboratoire de Biophotonique et Pharmacologie, UMR CNRS 7213, Faculté de Pharmacie, Université de Strasbourg, F67401 Illkirch, France
| | - Benito Casu
- From the Istituto di Ricerche Chimiche e Biochimiche 'G. Ronzoni', via G. Colombo 81, 20133 Milan, Italy
| | - Giangiacomo Torri
- From the Istituto di Ricerche Chimiche e Biochimiche 'G. Ronzoni', via G. Colombo 81, 20133 Milan, Italy
| | - Marco Guerrini
- From the Istituto di Ricerche Chimiche e Biochimiche 'G. Ronzoni', via G. Colombo 81, 20133 Milan, Italy,.
| |
Collapse
|